EUVIMEDOpdag EUVIMED
VergleichsstudieOpen access

A Comparison of British and US Pharmacopoeia Standards for Quality of Ashwagandha Dietary Supplements in Commerce

Bharathi Avula iD, Kumar Katragunta iD, Kiran Kumar Tatapudi, Yan-Hong Wang, Amar G Chittiboyina iD, Ikhlas A Khan iD

Phytotherapy Research · 2026-08 · 40 (8) · 4833-4844

DOI: 10.1002/ptr.70148 ↗

At a glance

Vergleichsstudie in Phytotherapy Research, published online on 2025-12-12. Written by Bharathi Avula and 5 co-authors. Institution: National Center for Natural Products Research, University of Mississippi, Oxford, Mississippi, USA. Major MEDLINE topics: Dietary Supplements, Pharmacopoeias as Topic, Withania. Cited 1 times so far (Crossref); 22 references. The full text is freely available in PubMed Central. Funded by: U.S. Department of Agriculture, U.S. Food and Drug Administration, Agricultural Research Service.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Pharmacopeias are essential for ensuring the quality of botanical raw materials, yet their utility is limited by slow adaptation to rapid innovation in the dietary supplement industry. Challenges arise from differing standards (e.g., the British Pharmacopoeia (BP) and the United States Pharmacopoeia (USP)), as well as a critical lack of comparative data for globally sourced ingredients. The post‐COVID surge in adaptogens, such as ashwagandha, underscores the urgency of these issues. The commercial use of aerial parts—despite traditional root‐only use and phytochemical variability—raises concerns about quality and safety. The situation necessitates rigorous source verification and re‐evaluation of current pharmacopeial methods. To address these deficiencies, we developed and compared an HPLC‐PDA method utilizing BP and USP standards to quantify three steroidal lactones (withaferin A, withanolide A, and withanoside IV) in ashwagandha samples and commercial products. Our analysis revealed substantial variations in steroidal lactone content. Alarmingly, over 44% of products failed to meet BP standards, and 60% failed to meet USP standards. The high failure rate was attributed to the elevated presence of co‐eluted dihydrowithaferin sulfate, primarily found in leaf samples, which led to an underestimation of withanolide A. Only 10 of 25 supplement products met both standards; only two were confirmed as root‐derived, while the remainder contained varying proportions of (un)disclosed aerial parts. These findings highlight critical plant‐part‐specific chemical variations and the need for enhanced source verification and improved quality control. Developing robust analytical methods and revisiting existing pharmacopeial guidelines are crucial for assessing the quality and safety of ashwagandha products, including novel formulations.

Subjects

MeSH terms (MEDLINE)

Dietary SupplementsPharmacopoeias as TopicWithaniaUnited StatesUnited KingdomChromatography, High Pressure LiquidQuality ControlPlant Extracts

Author keywords

HPLC‐PDAashwagandhadietary supplementspharmacopeial methodsquality

Substances

AshwagandhaPlant Extracts

Authors and institutions

  • National Center for Natural Products Research, University of Mississippi, Oxford, Mississippi, USA.
  • Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, Oxford, Mississippi, USA.
  • Department of Chemistry and Biochemistry, University of Mississippi, Oxford, Mississippi, USA.

ORCID profiles: Bharathi Avula, Kumar Katragunta, Amar G Chittiboyina, Ikhlas A Khan

Funding

  • U.S. Department of Agriculture
  • U.S. Food and Drug Administration
  • Agricultural Research Service
  • FDA HHS
  • Center for Food Safety and Applied Nutrition

Cite

APA

Avula, B., Katragunta, K., Tatapudi, K. K., Wang, Y. H., Chittiboyina, A. G., & Khan, I. A. (2026). A Comparison of British and US Pharmacopoeia Standards for Quality of Ashwagandha Dietary Supplements in Commerce. Phytotherapy Research, 40(8), 4833-4844. https://doi.org/10.1002/ptr.70148

Vancouver

Avula B, Katragunta K, Tatapudi KK, Wang YH, Chittiboyina AG, Khan IA. A Comparison of British and US Pharmacopoeia Standards for Quality of Ashwagandha Dietary Supplements in Commerce. Phytotherapy Research. 2026;40(8):4833-4844. doi:10.1002/ptr.70148

BibTeX
@article{Avula2026,
  author = {Avula, Bharathi and Katragunta, Kumar and Tatapudi, Kiran Kumar and Wang, Yan-Hong and Chittiboyina, Amar G and Khan, Ikhlas A},
  title = {A Comparison of British and US Pharmacopoeia Standards for Quality of Ashwagandha Dietary Supplements in Commerce},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {4833--4844},
  doi = {10.1002/ptr.70148}
}
Start for free →